Literature DB >> 29353709

The role of telenursing in the management of Diabetes Type 1: A randomized controlled trial.

Konstantia Kotsani1, Vasiliki Antonopoulou1, Aikaterini Kountouri1, Maria Grammatiki1, Eleni Rapti1, Spyridon Karras1, Christina Trakatelli1, Panagiotis Tsaklis2, Kiriakos Kazakos2, Kalliopi Kotsa3.   

Abstract

BACKGROUND: Diabetes Mellitus type 1 (T1DM) is a chronic disease that requires patients' self-monitoring and self-management to achieve glucose targets and prevent complications. Telenursing implicates technology in the interaction of a specialized nurse with patients with chronic diseases in order to provide personalized care and support.
OBJECTIVE: To evaluate the effect of telenursing on T1DM patients' compliance with glucose self-monitoring and glycemic control.
DESIGN: Randomized controlled study. SETTINGS: Outpatient Department of Diabetes, Endocrinology and Metabolism of a University Hospital in Northern Greece.
METHODS: Ninety-four T1DM patients were recruited and randomized in two groups by a random number generator. The intervention group (N = 48) was provided with telenursing services. A specialized nurse made a weekly contact via telephone motivating patients to frequently measure blood glucose and adopt a healthy lifestyle. The control group (N = 46) received standard diabetes advice and care in the clinic. The primary outcome was the effect of the intervention in glucose control and glucose variability. The secondary outcome was the effect on frequency of self-monitoring. SPSS 20.0 was used for data analysis.
RESULTS: The two groups did not differ in age, sex, physical activity or initial HbA1c. In the intervention group, blood glucose significantly decreased at the end of the study in all predefined measurements, compared to control group: morning (93.18 ± 13.30 mg/dl vs. 105.17 ± 13.74 mg/dl, p < 0.005), pre-prandial (114.76 ± 9.54 mg/dl vs. 120.84 ± 4.05 mg/dl, p < 0.005), post-prandial (193.35 ± 25.36 mg/dl vs. 207.84 ± 18.80 mg/dl, p < 0.005), and HbA1c decreased significantly over time in the intervention group (8.3 ± 0.6% at the beginning of the study vs. 7.8 ± 1% at the end of the study, p = 0.03). In the intervention group there were also fewer omitted glucose measurements than in the control group.
CONCLUSIONS: Patients in the intervention group achieved better glucose control and more frequent self-monitoring than patients in routine care in the clinic. The findings of our study indicate that telenursing can motivate T1DM patients to better control their disease.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes management; Diabetes type 1; Monitoring; Nursing care; Telenursing

Mesh:

Substances:

Year:  2018        PMID: 29353709     DOI: 10.1016/j.ijnurstu.2018.01.003

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  5 in total

1.  Effectiveness of Telenursing for Postoperative Complications in Patients with Prostate Cancer.

Authors:  Daisuke Sato
Journal:  Asia Pac J Oncol Nurs       Date:  2020-09-14

2.  The efficacy of telenursing on caregiver burden among Iranian patients with heart failure: A randomized clinical trial.

Authors:  Mohaddeseh Namjoo; Monirsadat Nematollahi; Mozhgan Taebi; Masoumeh Kahnooji; Roghayeh Mehdipour-Rabori
Journal:  ARYA Atheroscler       Date:  2021-11

Review 3.  Health system responses for type 1 diabetes: A scoping review.

Authors:  Jessica H Zafra-Tanaka; David Beran; Antonio Bernabe-Ortiz
Journal:  Diabet Med       Date:  2022-02-24       Impact factor: 4.213

Review 4.  Personalized Care Management for Persons with Parkinson's Disease.

Authors:  Angelika D van Halteren; Marten Munneke; Eva Smit; Sue Thomas; Bastiaan R Bloem; Sirwan K L Darweesh
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

5.  How Parents Cope with the Care of a Child with Epilepsy: Based upon Grounded Theory.

Authors:  Behnaz Bagherian; Monirsadat Nematollahi; Roghayeh Mehdipour-Rabori
Journal:  Ethiop J Health Sci       Date:  2021-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.